Free Trial

Zacks Research Weighs in on Select Medical Q1 Earnings

Select Medical logo with Medical background
Remove Ads

Select Medical Holdings Co. (NYSE:SEM - Free Report) - Analysts at Zacks Research issued their Q1 2025 EPS estimates for Select Medical in a note issued to investors on Thursday, March 6th. Zacks Research analyst Z. Masood anticipates that the health services provider will post earnings per share of $0.43 for the quarter. The consensus estimate for Select Medical's current full-year earnings is $1.17 per share. Zacks Research also issued estimates for Select Medical's Q2 2025 earnings at $0.25 EPS, Q3 2025 earnings at $0.20 EPS, Q4 2025 earnings at $0.27 EPS, FY2025 earnings at $1.15 EPS, Q1 2026 earnings at $0.31 EPS, Q2 2026 earnings at $0.50 EPS, Q3 2026 earnings at $0.32 EPS, Q4 2026 earnings at $0.31 EPS and FY2026 earnings at $1.44 EPS.

Several other equities research analysts have also issued reports on SEM. StockNews.com raised shares of Select Medical from a "hold" rating to a "buy" rating in a report on Friday, February 21st. Royal Bank of Canada lowered their target price on shares of Select Medical from $47.00 to $23.00 and set an "outperform" rating on the stock in a research note on Monday, February 24th. UBS Group cut their price target on shares of Select Medical from $40.00 to $21.00 and set a "neutral" rating for the company in a research note on Friday, January 3rd. Finally, Benchmark upgraded Select Medical from a "hold" rating to a "buy" rating and set a $23.00 price target on the stock in a research report on Monday, February 24th. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company's stock. According to MarketBeat.com, Select Medical presently has a consensus rating of "Moderate Buy" and a consensus target price of $27.25.

Remove Ads

Get Our Latest Stock Analysis on Select Medical

Select Medical Stock Performance

Select Medical stock traded down $0.26 during mid-day trading on Monday, reaching $16.53. The company had a trading volume of 428,948 shares, compared to its average volume of 739,744. The company has a 50 day moving average of $18.84 and a 200-day moving average of $26.55. Select Medical has a 52 week low of $16.20 and a 52 week high of $40.98. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. The firm has a market cap of $2.13 billion, a price-to-earnings ratio of 10.04, a PEG ratio of 0.64 and a beta of 1.56.

Select Medical (NYSE:SEM - Get Free Report) last released its quarterly earnings results on Thursday, February 20th. The health services provider reported $0.18 earnings per share for the quarter, missing analysts' consensus estimates of $0.29 by ($0.11). The business had revenue of $1.31 billion for the quarter, compared to the consensus estimate of $1.50 billion. Select Medical had a net margin of 3.23% and a return on equity of 14.04%.

Select Medical Cuts Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, March 13th. Stockholders of record on Monday, March 3rd will be given a dividend of $0.0625 per share. The ex-dividend date is Monday, March 3rd. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.51%. Select Medical's payout ratio is currently 15.15%.

Institutional Investors Weigh In On Select Medical

A number of institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. raised its holdings in shares of Select Medical by 1.0% during the fourth quarter. Vanguard Group Inc. now owns 12,712,990 shares of the health services provider's stock worth $239,640,000 after acquiring an additional 131,228 shares during the period. Dimensional Fund Advisors LP raised its holdings in shares of Select Medical by 1.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 4,431,469 shares of the health services provider's stock valued at $83,533,000 after purchasing an additional 62,585 shares during the period. Invesco Ltd. lifted its position in shares of Select Medical by 48.6% in the fourth quarter. Invesco Ltd. now owns 2,643,943 shares of the health services provider's stock valued at $49,838,000 after buying an additional 864,852 shares during the last quarter. Geode Capital Management LLC boosted its position in Select Medical by 2.0% during the third quarter. Geode Capital Management LLC now owns 2,442,321 shares of the health services provider's stock worth $85,180,000 after purchasing an additional 46,880 shares during the period. Finally, Principal Financial Group Inc. boosted its holdings in shares of Select Medical by 1.9% during the 4th quarter. Principal Financial Group Inc. now owns 2,403,508 shares of the health services provider's stock worth $45,310,000 after buying an additional 45,685 shares during the period. 89.48% of the stock is owned by institutional investors and hedge funds.

About Select Medical

(Get Free Report)

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

Featured Articles

Earnings History and Estimates for Select Medical (NYSE:SEM)

Should You Invest $1,000 in Select Medical Right Now?

Before you consider Select Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.

While Select Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Trump Tariffs Tumble the Stock Market—Here’s How to Protect Your Money
Donald Trump Owns These 7 Stocks, Should You?
 5 Stocks to BUY NOW in April 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads